Member Info for scardey_cat

Apologies to Rebecca and other female shareholders, Day360 was not my finest moment. I'm actually quite a 'modern' man...just having a bit of fun.

Day 90: Buy Aston Martin DB11 Volante
Day180: Buy Marbella villa with swimming pool
Day270: Buy yacht
Day360: Get divorced (sell some shares to sort out the Mrs)
Day367: Meet really hot young woman
Day367->Live happily ever after

InfinisandBeyond:
I attended a webinar on Wednesday given by Chris Beauchamp, IG's chief market analyst, entitled 'Trading beyond lockdown'. It's now gone live on IG. He talks about all the topics you mention in your post. Worth a listen:

https://www.ig.com/uk/market-insight-articles/trading-beyond-lockdown-210513?CHID=3&QPID=37894&tid=416ee91ab6cd6e1b087f22ed3b24cd59

The denoument...he actually read the LSE script!...ha ha.

Good Morning Martin,

No problem at all, I have been in the industry over 26 years, so not much I haven’t seen, although this is certainly a new one on me. As with all Medical and IVD companies, confidentiality is the cornerstone of the industry, and to that extent I’m sure you’ll understand I cannot give any details of the test. I would further urge caution in any future adventures, as if you had completed the study, regardless of the test in question, and that data had made it into the public domain before the study is reported, the whole study would have been invalidated. To that point I really appreciate your transparency and openness to prevent this.

With respect to useability in general, this information is in the public domain. The objective of these studies are to test the ability of individuals without specialist training or knowledge to use and understand the results of the device in question. Generally these studies aim to demonstrate that users can:

- Take a sample easily and correctly.
- Use the device as per the instructions
- Be able to read the result
- Understand the result and what to do with that result.

Usability studies target all demographic groups, but exclude people with prior knowledge or ‘expertise’ in a given test. The users are scored for example: through questionnaires and dedicated silent observers. Further information is available on the MHRA and government websites.

As for mid to late 30’s this certainly made my day! I’m currently in the process of framing this for my desk, and Ill be trading on this for a long time…

I wish you and ‘Robbo’ all the very best for all of your investments.

Kind regards

Christian

Explains why tsales is getting adverts for strategies on increasing your IQ, Richob.

Yes, MrA...I know, I know, a very unfortunate choice. I'll wear my David Silva shirt today to absolve myself from that crime.

Just a quick update. I had to phone Medusa to get Christian's email address as it was incorrect on their website. The guy thanked me very much and said he would be straight on to the IT department. So, third time lucky, email sent to chris.stephenson@medusa19.com. And, just for you Timster, I changed the last paragraph to:

"And, by the way, if you do "need the numbers" as you mentioned, I can guarantee you about 500 Avacta shareholders at your next event to get things off to a good start, though I suspect you might get a rather large subset of extremely high marks for usability :-)"

And, removed all my bad spelling mistakes!

"Also hope for confirmation that the test is effective in identifying the India variant."

Yep, confirmation of Indian variant detection would be very noteworthy at this point.

Reuters
May 14, 20218:19 AM BST
Positive virus tests keep 75 Australians off flight home from India
Nearly half the 150 passengers booked on Australia's first repatriation flight from India were barred from boarding on Friday, after they or their close contacts tested positive for the coronavirus, an Australian government source said.
Tests have returned positive results for at least 40 passengers, or about 26% of the total, said the source, who sought anonymity as he was not allowed to speak to media, a figure much higher than the 3.5% seen in March.
By late afternoon, Australian media said that number was rising, with 9News and Sky reporting 48 infections and about 25 close contacts. Reuters was unable to verify that information.

Had to send it again, misspelt the email address...bloody senility!

From: xxxxxxxxx@hotmail.com
Sent: 14 May 2021 08:27
To: 'christian.stephenson@mdeusa19.com'
Subject: Alderley Park Rapid Test Study

Dear Christian

Please forgive this unsolicited email, but I had occasion to meet you at Alderley Park on Wednesday and wanted to share with you an amusing script, borne out of Wednesday's event.

Just to jog your memory, myself (in red jacket), alongside 'Robbo', attended the event at around 3pm on Wednesday. We were the two rather desperate and dissapointed attendees who arrived just as you had run out of tests to administer. As I explained to you, we are investors in Avacta and were, in a way, representing many investors who frequent the Avacta LSE chatboard. Our attendance at the event generated quite a lot of excitement on the chatboard, leading to a quite colourful dialogue on there throughout the day. It occured to me that you may find this script amusing, as you feature as the lead character to a large extent. I've attached a word document with the full script. You have to start at the bottom and work your way to the top.

Being aware of the sensetivities and confidentialities surrounding the event, I can assure you that the contributions to the LSE chatboard were fun in nature; and any assertions made that the Avacta antigen test was the subject of the usability study were just wild speculation on my part, in the main due to the very professional, descrete and impressive manner you displayed when 'batting off' my probing questions.

That said, you would make a lot of Avacta shareholders extremely happy, if you could find it within yourself to share with us a copy of the usability study questionaire. It would inform our research significantly, as we noted the low usabilty score for the Mologic antigen test (57/100) in the FIND S&S study and are very keen to understand the approach taken when assessing usability. I hope you agree that this information would not be regarded as confidential, since it was freely available at the event and read by many attendees and you would in no way be acknowledging that Avacta had anything to do with the study. And, just to push my luck a bit, could you possibly share with us the number of attendees you were able to attract to the event over the course of Tuesday and Wednesday?

You were kind enough to take my contact details on the day, with a view to inviting me to the next usability study. I hope the possibilty of such an invite still exists, despite my sleuth like activities on Wednesday :-). And, by the way, if you do "need the numbers" as you stated on Wednesday, I can gaurantee you about 500 Avacta shareholders at your next event to get things off to a good start.

Many thanks and kind regards

Brilliant ENTANGLED, really made me chuckle that.

By the way, my mate Christian says about Medusa "We're up to a supply chain of 100mil/month."
https://www.facebook.com/watch/?v=626686341553503

I'm going to dig around for his email address and email him the full LSE script of Wednesday's mission impossible (leaving out the bit about the bins, of course). I think he'll find it very amusing. At the same time I'll ask him for a copy of the usability questionnaire and ask him about the number of attendees at Alderley Park. Hopefully, he'll oblige as I don't think he'll see this as being confidential info.

Yes, Boohoo are right across the road from Medusa on Dale St. Be handy for re-assigning some of the Boohoo machinists onto the Ginolis, whilst Boo's a bit quiet on the party frock front. Also got Genedrive around these parts. Great things happening in Manchester...including the footy!

trading4good, It's listed on Medusa's website as their head office. Also, noticed that Glassouse, Alderley Park is listed as their 'Scientific HQ'.

No problem Rorkes, would just need another fund raise setting up for the bail.

Wiggly, I think the bins are empted on a Wednesday. That'd be today then wouldn't it?

Yeh, I'm sure I wouldn't be noticed snooping around there like a member of the Village People PL. Actually, it's just in the spot where the famous Foo Foo Lammar's night club used to be, so perhaps I'd get away with it.

For a bit of fun, I just had a look at 20 Dale St, Manchester on Google maps (I actually used to work around the corner many moons ago). So, there's protective boarding up around a significant portion of the building with major works going on, with Kamani Property Group logo plastered all over it. I happened to notice the wheely bins are temptingly accessible during the day (when side gates are open). Feeling on a bit of a roll, I'm finding it hard to resist silly notions coming into my head. I couldn't, could I? Robbo, what you up to tomorrow?

After mentioning GAD, BBI & ABDX as our known manufacturers, AS says in Apr21 presentation:

"And there are other UK manufacturers that we would certainly hope to access"

https://avacta.com/preliminary-results-for-the-year-ending-31-december-2020-webinar-presentation/
(21:51 m/s)

PL: In all modesty, I'll say that it feels quite good knowing you can hold your own in a conversation about viral loads and ct values, with the Chief Development Officer of Medusa19.

By the way, my girlfriend couldn't stop laughing at your comment yesterday..."I’m not sure sending someone that’s clearly senile over there is a good idea. Is anyone else free?". Have to say, it cracked me up too on reading it later in the day.

Here's a picture of Christian Stephenson/Medusa19 at a similar rapid test study in Wilmslow in January this year – 3 miles down the road from yesterday's venue, Alderley Park. 2nd picture down, 3rd in from the left.

https://www.knutsfordguardian.co.uk/news/19019755.wilmslow-children-take-part-covid-19-rapid-test-study/

The Wilmslow study was in reference to the Medusa19 RSPT test. Note: they did follow up with PCR test in the Wilmslow study, so we might expect PCR follow up from yesterday’s study, adding to the S&S profile.

I think we can now call it. Medusa19's Chief Development Officer, Christian Stephenson, was at the Glasshouse, Alderley Park yesterday, overseeing the study of a test that originated ‘somewhere in Cambridgeshire’. In my view, the Avacta test was the subject of this study.

Why:
- The study was headlined “New Covid-19 ANTIGEN Test Usability Study – Help test the usability of a NEW, NON-INTRUSIVE, Covid-19 Nasal Test”. From what we know about the Medusa19/Avacta agreement, we have to deduce this couldn’t be any other rapid antigen test
- The test originated from ‘somewhere in Cambridgeshire’.
- The Wilmslow study didn’t take place in secret, the test was identified in a local newspaper article, whereas, the Alderley Park study yesterday was fully blind and CS was very keen to be keep it under wraps.

Takeaways:
- Christian Stephenson was ‘broad grinned’ pleased with the results of the usability study…so we can expect top marks for Avacta’s usability score.
- CS said “I wish we had more tests guys, we need the numbers”, implying a measure of urgency associated with the study
- The study appeared to employ a self-swab method of sample collection
- At high viral loads the test gives an obvious / distinct positive line ‘fairly quickly’ (CS words)
- Medusa19 took the trouble to send a senior company officer down to oversee this study, indicating seriousness of purpose/intent. CS stated in the BBC Northwest interview “We’re up to a supply chain of 100 mil tests per month” – surely this cannot all be for the RSPT test (antibody test)

It’s happening guys.

Timster, it was us, it is us and it will be us.

Big shout out to Poirot for first spotting this study yesterday afternoon. Just give us a bit more notice next time Pal :-)

Thanks for the confirmation Robbo mate. Nice to know my senility hasn't progressed too far yet :-)